date:Jun 09, 2012
Kemin marketing manager in human nutrition and health, Miguel Martinho, told us this morning the lutein compatriots were,surprised, baffled and annoyedby the latest opinion of EFSAs Panel on Dietetic Products, Nutrition and Allergies (NDA) that there wasinsufficientevidence to back their claim.
Aside from any perceived issues about the NDA treatment of the evidence submitted in the article 13.1 dossier, the companies were must frustrated, Martinho said, by the change in claim wording instigated